GLP-1 Drugs Market to Reach USD 132.79 Billion by 2035 as Oral Therapies, Tirzepatide and Obesity Applications Reshape Competition
The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.
Solo un extracto — este editor licencia su texto. Lea el comunicado completo en la fuente.
Cancele cuando quiera · 99 CA$/mes


